rs397517034
Positions:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_004985.5(KRAS):c.-160_-158dupAGC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00164 in 250,204 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0024 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00045 ( 0 hom. )
Consequence
KRAS
NM_004985.5 5_prime_UTR
NM_004985.5 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.294
Genes affected
KRAS (HGNC:6407): (KRAS proto-oncogene, GTPase) This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 12-25250896-C-CGCT is Benign according to our data. Variant chr12-25250896-C-CGCT is described in ClinVar as [Likely_benign]. Clinvar id is 45111.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00241 (366/152074) while in subpopulation AFR AF= 0.00838 (348/41534). AF 95% confidence interval is 0.00765. There are 2 homozygotes in gnomad4. There are 172 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 366 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRAS | NM_004985.5 | c.-160_-158dupAGC | 5_prime_UTR_variant | 1/5 | ENST00000311936.8 | NP_004976.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRAS | ENST00000311936.8 | c.-160_-158dupAGC | 5_prime_UTR_variant | 1/5 | 1 | NM_004985.5 | ENSP00000308495.3 |
Frequencies
GnomAD3 genomes AF: 0.00240 AC: 365AN: 151966Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
365
AN:
151966
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000448 AC: 44AN: 98130Hom.: 0 Cov.: 0 AF XY: 0.000474 AC XY: 25AN XY: 52784
GnomAD4 exome
AF:
AC:
44
AN:
98130
Hom.:
Cov.:
0
AF XY:
AC XY:
25
AN XY:
52784
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00241 AC: 366AN: 152074Hom.: 2 Cov.: 32 AF XY: 0.00231 AC XY: 172AN XY: 74352
GnomAD4 genome
AF:
AC:
366
AN:
152074
Hom.:
Cov.:
32
AF XY:
AC XY:
172
AN XY:
74352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3416
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 12, 2011 | -160_-158dupAGC in KRAS 5' UTR: This variant has not been previously reported in the literature or been identified in our laboratory. The 5' UTR plays a role in the regulation of gene expression and variants in this region have been shown t o alter protein translation (Mendell 2001, Scheper 2007). This type of variant h as not been previously reported in an individual with a Noonan spectrum disorder . - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at